Exosomal long non-coding RNAs in cancer : interplay, modulation, and therapeutic avenues

dc.contributor.authorMarima, Rahaba
dc.contributor.authorBasera, Afra
dc.contributor.authorMiya, Thabiso Victor
dc.contributor.authorDamane, Botle Precious
dc.contributor.authorKandhavelu, Jeyalakshmi
dc.contributor.authorMirza, Sheefa
dc.contributor.authorPenny, Clement
dc.contributor.authorDlamini, Zodwa
dc.contributor.emailrahaba.marima@up.ac.zaen_US
dc.date.accessioned2025-02-28T07:08:35Z
dc.date.available2025-02-28T07:08:35Z
dc.date.issued2024-09
dc.description.abstractIn the intricate field of cancer biology, researchers are increasingly intrigued by the emerging role of exosomal long non-coding RNAs (lncRNAs) due to their multifaceted interactions, complex modulation mechanisms, and potential therapeutic applications. These exosomal lncRNAs, carried within extracellular vesicles, play a vital partin tumorigenesis and disease progression by facilitating communication networks between tumor cells and their local microenvironment, making them an ideal candidates for use in a liquid biopsy approach. However, exosomal lncRNAs remain an understudied area, especially in cancer biology. Therefore this review aims to comprehensively explore the dynamic interplay between exosomal lncRNAs and various cellular components, including interactions with tumor-stroma, immune modulation, and drug resistance mechanisms. Understanding the regulatory functions of exosomal lncRNAs in these processes can potentially unveil novel diagnostic markers and therapeutic targets for cancer. Additionally, the emergence of RNA-based therapeutics presents exciting opportunities for targeting exosomal lncRNAs, offering innovative strategies to combat cancer progression and improve treatment outcomes. Thus, this review provides insights into the current understanding of exosomal lncRNAs in cancer biology, highlighting their crucial roles, regulatory mechanisms, and the evolving landscape of therapeutic interventions. Furthermore, we have also discussed the advantage of exosomes as therapeutic carriers of lncRNAs for the development of personalized targeted therapy for cancer patients.en_US
dc.description.departmentMedical Oncologyen_US
dc.description.departmentSurgeryen_US
dc.description.librarianam2024en_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.sponsorshipThe University of Pretoria (UP) Research Development Programme (RDP); UP Development Fund; The South African Medical Research Council (SAMRC); the National Research Foundation (NRF).en_US
dc.description.urihttp://www.keaipublishing.com/en/journals/non-coding-rna-researchen_US
dc.identifier.citationMarima, R., Basera, A., Miya, T. et al. 2024, 'Exosomal long non-coding RNAs in cancer : interplay, modulation, and therapeutic avenues', Non-coding RNA Research, vol. 9, pp. 887-900. https://DOI.org/10.1016/j.ncrna.2024.03.014.en_US
dc.identifier.issn2468-0540
dc.identifier.other10.1016/j.ncrna.2024.03.014
dc.identifier.urihttp://hdl.handle.net/2263/101274
dc.language.isoenen_US
dc.publisherKeAi Communications Co.en_US
dc.rights© 2024 The Authors. This is an open access article under the CC BY-NC-ND license.en_US
dc.subjectExosomesen_US
dc.subjectExosomal lncRNAsen_US
dc.subjectCanceren_US
dc.subjectIntercellular and intracellular communicationen_US
dc.subjectBiomarkersen_US
dc.subjectLong non-coding RNAs (lncRNAs)en_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.titleExosomal long non-coding RNAs in cancer : interplay, modulation, and therapeutic avenuesen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Marima_Exosomal_2024.pdf
Size:
2.84 MB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: